A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...

King’s College London researchers discovered that parts of our DNA once thought to be “junk” can actually help destroy cancer ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The drug, which is an NLRP3 inhibitor, also reduced other key cardiovascular risk biomarkers. Ventyx Biosciences plans to ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

While anti-VEGF therapies remain the current standard of care, many DME patients experience suboptimal responses due to ...

Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...

The "atopic march" describes the age-related progression of allergic diseases, presenting as the sequential onset of atopic ...